Home > Balance Sheet > MARKSANS PHARMA

MARKSANS PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹268 Cr₹273 Cr₹205 Cr₹84 Cr₹57 Cr

What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?

The latest Total Non-Current Liabilities ratio of MARKSANS PHARMA is ₹268 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹268 Cr
Mar2025₹273 Cr
Mar2024₹205 Cr
Mar2023₹84 Cr
Mar2022₹57 Cr

How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹268 Cr
-1.74
Mar2025 ₹273 Cr
33.00
Mar2024 ₹205 Cr
143.34
Mar2023 ₹84 Cr
47.80
Mar2022 ₹57 Cr -

Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹13,738.8 Cr -4.4% -5% 74.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -1.4% -6.5% 5.5% Stock Analytics
DIVIS LABORATORIES ₹241,311.0 Cr -2% -2.7% 40.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,079.0 Cr -1.8% -7% 29.6% Stock Analytics
CIPLA ₹107,528.0 Cr 0.1% -3% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,667.0 Cr 0.2% 6% -2.4% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-4.4%

-5%

74.9%

SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses